Skip to main content
Zura Bio Ltd logo

Zura Bio Ltd — Investor Relations & Filings

Ticker · ZURA ISIN · KYG507521071 LEI · 549300LQXD6M2MIQFN24 US Manufacturing
Filings indexed 394 across all filing types
Latest filing 2026-05-22 Proxy Solicitation & In…
Country KY Cayman Islands
Listing US ZURA

About Zura Bio Ltd

https://zurabio.com/

Zura Bio Ltd. is a multi-asset, clinical-stage biotechnology company focused on developing novel medicines for severe autoimmune and inflammatory disorders. The company's strategy centers on dual-pathway biology, aiming to create transformative solutions for patients whose needs are not adequately met by single-pathway medicines. Its development portfolio includes the therapeutic candidates tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio's mission is to enhance patient well-being by developing innovative dual-pathway antibody therapies that demonstrate efficacy, safety, and dosing convenience for challenging immunological conditions.

Recent filings

Filing Released Lang Actions
DEFA14A
Proxy Solicitation & Information Statement
2026-05-22 English
FORM 8-K
Regulatory Filings
2026-05-22 English
8-K - Zura Bio Ltd (0001855644) (Filer)
Regulatory Filings
2026-05-07 English
10-Q - Zura Bio Ltd (0001855644) (Filer)
Interim / Quarterly Report
2026-05-07 English
ARS - Zura Bio Ltd (0001855644) (Filer)
Annual Report
2026-04-30 English
8-K - Zura Bio Ltd (0001855644) (Filer)
Regulatory Filings
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.